D. Varges

发表

Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.

B. Steinhoff, K. Kallenberg, U. Heinemann, 2007, Brain : a journal of neurology.

Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia

D. Varges, I. Zerr, F. Llorens, 2018, European Archives of Psychiatry and Clinical Neuroscience.

MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter‐observer agreement study

K. Kallenberg, U. Heinemann, A. Krasnianski, 2008, European journal of neurology.

Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease

D. Varges, I. Zerr, F. Llorens, 2022, Molecular Neurobiology.

8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases

U. Heinemann, D. Varges, I. Zerr, 2009, Neurodegenerative Diseases.

A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia

G. Escaramís, J. D. del Río, D. Varges, 2020, Journal of Neurology.

Chromogranin A Analysis in the Differential Diagnosis Across Lewy Body Disorders.

D. Varges, I. Zerr, K. Gmitterová, 2020, Journal of Alzheimer's disease : JAD.

Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy

J. Trojanowski, V. Lee, H. Vanderstichele, 2018, Molecular Neurobiology.

Prospective CERAD Neuropsychological Assessment in Patients With Multiple System Atrophy

A. Leha, D. Varges, I. Zerr, 2022, Frontiers in Neurology.

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies

D. Varges, I. Zerr, F. Llorens, 2021, Frontiers in Aging Neuroscience.

Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2006, BMC neurology.

Differenzialdiagnose rasch progredienter Demenzen

U. Heinemann, A. Krasnianski, B. Meissner, 2007 .

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline

B. Mollenhauer, D. Varges, I. Zerr, 2022, Diagnostics.

Fatal familial insomnia: Clinical features and early identification

U. Heinemann, A. Krasnianski, B. Meissner, 2008, Annals of neurology.

Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie

D. Varges, W. Schulz-Schaeffer, I. Zerr, 2016, Scientific Reports.

Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases

A. Karch, D. Varges, I. Zerr, 2014, Molecular Neurobiology.

Genetic prion disease with codon 196 PRNP mutation: clinical and pathological findings

H. Kretzschmar, D. Varges, I. Zerr, 2011, Neurobiology of Aging.

Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt–Jakob disease

D. Varges, I. Zerr, M. Beekes, 2010, The European journal of neuroscience.

Clinical Features and Diagnosis of the MM 2 Cortical Subtype of Sporadic Creutzfeldt-Jakob Disease

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2006 .

Low-abundant cerebrospinal fluid proteome alterations in dementia with Lewy bodies.

U. Heinemann, D. Varges, I. Zerr, 2013, Journal of Alzheimer's disease : JAD.

Plasma YKL-40 in the spectrum of neurodegenerative dementia

D. Varges, I. Zerr, F. Llorens, 2019, Journal of Neuroinflammation.

Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases

B. Mollenhauer, P. Liberski, D. Varges, 2017, Alzheimer's & Dementia.

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

B. Mollenhauer, D. Varges, I. Zerr, 2016, Journal of Neurology.

Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia

A. Karch, D. Varges, I. Zerr, 2016, Alzheimer's & Dementia.

Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease

A. Karch, D. Varges, I. Zerr, 2015, Molecular Neurobiology.

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease

C. Begue, R. G. Will, J. P. Brandel, 2009, Brain : a journal of neurology.

Movement disturbances in the differential diagnosis of Creutzfeldt‐Jakob disease

B. Mollenhauer, U. Heinemann, D. Varges, 2009, Movement disorders : official journal of the Movement Disorder Society.

Explorer Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease

G. Jansen, K. Kallenberg, P. Smith, 2016 .

Clinical course in young patients with sporadic Creutzfeldt–Jakob disease

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2005, Annals of neurology.

Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein gene

M. Faist, K. Kallenberg, D. Varges, 2013, Journal of Neurology.

Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases

K. Blennow, I. Ferrer, A. Karch, 2018, Alzheimer's & Dementia.

Doxycycline in early CJD: a double-blinded randomised phase II and observational study

Tim Friede, Walter J Schulz-Schaeffer, T. Friede, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease

K. Blennow, D. Varges, I. Zerr, 2021, Alzheimer's Research & Therapy.

A proposal of new diagnostic pathway for fatal familial insomnia

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.

U. Heinemann, A. Krasnianski, D. Varges, 2011, Journal of Alzheimer's disease : JAD.

Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2006, Archives of neurology.

Sporadic Creutzfeldt–Jakob disease

K. Kallenberg, A. Krasnianski, B. Meissner, 2005, Neurology.

Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD.

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2006, Brain : a journal of neurology.

Isolated Cortical Signal Increase on MR Imaging as a Frequent Lesion Pattern in Sporadic Creutzfeldt-Jakob Disease

K. Kallenberg, U. Heinemann, A. Krasnianski, 2008, American Journal of Neuroradiology.

Clinical findings and diagnosis in genetic prion diseases in Germany

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2015, European Journal of Epidemiology.

Plasma YKL-40 in the spectrum of neurodegenerative dementia

D. Varges, I. Zerr, F. Llorens, 2019, Journal of Neuroinflammation.

Cerebrospinal Fluid Based Diagnosis in Alzheimer’s Disease

D. Varges, I. Zerr, J. Gawinecka, 2011 .

Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type

K. Kallenberg, H. Kretzschmar, A. Krasnianski, 2005 .

Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany.

U. Heinemann, A. Krasnianski, B. Meissner, 2017, Journal of Alzheimer's disease : JAD.

Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers

D. Varges, I. Zerr, I. Santana, 2022, Alzheimer's research & therapy.

Increased albumin CSF/serum ratio in dementia with Lewy bodies

D. Varges, I. Zerr, F. Llorens, 2015, Journal of the Neurological Sciences.

ORIGINAL RESEARCH Isolated Cortical Signal Increase on MR Imaging as a Frequent Lesion Pattern in Sporadic Creutzfeldt-Jakob Disease

K. Kallenberg, U. Heinemann, A. Krasnianski, 2008 .

Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy

J. Trojanowski, V. Lee, H. Vanderstichele, 2018, Molecular Neurobiology.

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

K. Blennow, I. Ferrer, O. Hansson, 2020, Nature Communications.

Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt–Jakob disease

D. Varges, I. Zerr, M. Beekes, 2010, The European journal of neuroscience.